ArticlePloS one2011
Dominating biological networks.
Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 113 citations in OpenAlex.
- Constructing the biomolecular networks associated with diabetic nephropathy and dissecting the effects of biomolecule variation underlying pathogenesis.Endocrine journal · 2024Article
- Constraint-based models for dominating protein interaction networks.IET systems biology · 2021Article
- Network analysis of synonymous codon usage.Bioinformatics (Oxford, England) · 2020Article
- The power of dynamic social networks to predict individuals' mental health.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2020Article
- Network controllability analysis of intracellular signalling reveals viruses are actively controlling molecular systems.Scientific reports · 2019Article
- Finding and analysing the minimum set of driver nodes required to control multilayer networks.Scientific reports · 2019Article
- An integrative network-based approach to identify novel disease genes and pathways: a case study in the context of inflammatory bowel disease.BMC bioinformatics · 2018Article
- The phenotype control kernel of a biomolecular regulatory network.BMC systems biology · 2018Article
- Network analysis of the NetHealth data: exploring co-evolution of individuals' social network positions and physical activities.Applied network science · 2018Article
- Controllability in an islet specific regulatory network identifies the transcriptional factor NFATC4, which regulates Type 2 Diabetes associated genes.NPJ systems biology and applications · 2018Article
- GRAFENE: Graphlet-based alignment-free network approach integrates 3D structural and sequence (residue order) data to improve protein structural comparison.Scientific reports · 2017Article
- Critical controllability analysis of directed biological networks using efficient graph reduction.Scientific reports · 2017Article
- Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.PloS one · 2017Article
- Comparative analysis of housekeeping and tissue-specific driver nodes in human protein interaction networks.BMC bioinformatics · 2016Article
- Identification of key player genes in gene regulatory networks.BMC systems biology · 2016Article
- Article
- Critical controllability in proteome-wide protein interaction network integrating transcriptome.Scientific reports · 2016Article
- Analysis of the Effect of Degree Correlation on the Size of Minimum Dominating Sets in Complex Networks.PloS one · 2016Article
- Determining Associations between Human Diseases and non-coding RNAs with Critical Roles in Network Control.Scientific reports · 2015Article
- Novel drug target identification for the treatment of dementia using multi-relational association mining.Scientific reports · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteins are essential macromolecules of life that carry out most cellular processes. Since proteins aggregate to perform function, and since protein-protein interaction (PPI) networks model these aggregations, one would expect to uncover new biology from PPI network topology. Hence, using PPI networks to predict protein function and role of protein pathways in disease has received attention. A debate remains open about whether network properties of "biologically central (BC)" genes (i.e., their protein products), such as those involved in aging, cancer, infectious diseases, or signaling and drug-targeted pathways, exhibit some topological centrality compared to the rest of the proteins in the human PPI network.To help resolve this debate, we design new network-based approaches and apply them to get new insight into biological function and disease. We hypothesize that BC genes have a topologically central (TC) role in the human PPI network. We propose two different concepts of topological centrality. We design a new centrality measure to capture complex wirings of proteins in the network that identifies as TC those proteins that reside in dense extended network neighborhoods. Also, we use the notion of domination and find dominating sets (DSs) in the PPI network, i.e., sets of proteins such that every protein is either in the DS or is a neighbor of the DS. Clearly, a DS has a TC role, as it enables efficient communication between different network parts. We find statistically significant enrichment in BC genes of TC nodes and outperform the existing methods indicating that genes involved in key biological processes occupy topologically complex and dense regions of the network and correspond to its "spine" that connects all other network parts and can thus pass cellular signals efficiently throughout the network. To our knowledge, this is the first study that explores domination in the context of PPI networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.